LINC00839 and liver cancer: What's more, our data demonstrated that LINC00839 tended to increase in liver cancer cells under hypoxia compared with normoxia, with significant differences in SNU-387 and Li-7 liver cancer cells (Fig. 2D), which suggested that LINC00839 may be involved in the promoting effect of hypoxia on liver cancer progression.